039 - "The Camera Didn't Make the Artist Obsolete" with John Nosta

Let's Combinate · 29 Jun 2022 · 1h 04m

What this episode covers

John Nosta, founder of NostaLab and member of the Google Health Advisory Board, argues that the pharmaceutical industry must shift from a superficial 'patient-centric' marketing stance to 'technology-centric' drug discovery and 'patient-infused' care. He distinguishes between innovation and the implementation of existing technologies, citing telemedicine and genomic analysis as key areas where leveraging current tools offers immediate value. Nosta also explores the duality of wonder and fear surrounding AI, using tools like DALL-E and Tesla to illustrate how technology augments human capability rather than replacing clinicians.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 48m

    The Future of Healthcare & How We Get There

    Daniel Kraft, a physician-scientist and founder of Exponential Medicine and NextMed.Health, discusses the transition from reactive 'sick care' to proactive, continuous healthcare driven by digital health integration. He advocates for connecting disparate medical devices, wearables, and data sources to create holistic patient views, enabling personalized interventions and better clinical outcomes. Kraft highlights the importance of cross-industry collaboration, citing examples like using video game mechanics for mental health and 3D-printed personalized pills, while urging clinicians and developers to adopt new technologies and share data to accelerate innovation.

  • IoT For All Podcast · 20m

    IoT in AI, Computer Vision, and Simulation | NVIDIA's Adam Scraba | Internet of Things Podcast

    Adam Scraba, Director of Product Marketing at NVIDIA, discusses how IoT and AI are converging to turn static infrastructure into 'robots' through vision AI and digital twins. He explains that the massive deployment of networked cameras allows for superhuman perception, enabling applications in smart cities, retail, and manufacturing that prioritize safety and efficiency. Scraba highlights the shift from technology-driven solutions to domain-expert-driven applications, facilitated by accessible AI tools and simulation technologies like NVIDIA Metropolis.

  • Global Medical Device Podcast · 42m

    #439: MedTech AI Trends 2025: Scaling Regulatory Intelligence with Michelle Wu

    Michelle Wu, Founder and CEO of Nyquist AI, discusses the transformative impact of AI on the MedTech regulatory and quality assurance (RAQA) industry. She outlines the shift from AI skepticism to necessity, driven by the FDA’s ELSA framework and the EU AI Act, and introduces her 'Holy Trinity' framework of Data, Workflow, and Agents. Wu highlights how AI literacy can command a 56.8% salary premium for professionals and shares case studies of companies automating thousands of tasks, emphasizing that future success depends on asking high-quality strategic questions rather than memorizing knowledge.

  • Manufacturing Happy Hour · 1h 02m

    The Metaverse, MedTech, and the Ethics of Emergent Technology with Christopher Lafayette

    Christopher Lafayette, founder of GatherVerse and an emergent technologist, discusses the convergence of the metaverse, artificial intelligence, and medical technology. He explains how digital twins and immersive simulations are transforming MedTech by enabling remote surgical collaboration and optimizing hospital environments, while emphasizing the need for diversity and ethical standards in building these virtual ecosystems. Lafayette also addresses the rapid advancement of AI, warning of its imminent societal impact and the importance of getting accurate information from experts rather than relying on hype.

  • Global Medical Device Podcast · 42m

    #337: Moving MedTech Forward - The Past, Present & Future of Greenlight Guru

    David DeRam, CEO of Greenlight Guru, and Pall Johannesson, Managing Director of Greenlight Guru Clinical, discuss the 10-year history of their companies, including the acquisition of Smart Trial. They detail the strategic pivot of Smart Trial, where they discarded months of code to rebuild on robust technology, and the operational challenges of transitioning to remote work during the COVID-19 pandemic. The conversation highlights the company's focus on 'alligator blood' resilience, regulatory navigation like EU MDR, and the integration of AI into their quality management and clinical data platforms.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.